Kye-Hyun Kim

Title: Innovations by Kye-Hyun Kim

Introduction

Kye-Hyun Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable and oral drug formulations. With a total of two patents to his name, Kim's work focuses on enhancing the efficacy and safety of important medications.

Latest Patents

Kye-Hyun Kim's latest patents include an injectable composition of paclitaxel and a method and composition of an oral preparation of itraconazole. The injectable composition of paclitaxel is designed to provide an excellent anticancer effect. It comprises a solubilizer, such as polyoxyl hydrogenated castor oil, and stabilizers like N-acetyl amino acid. This formulation not only reduces toxicity but also improves solubility and stability at room temperature, allowing for effective venous injection. The second patent relates to an oral preparation of itraconazole, an azole antifungal drug. This preparation is characterized by improved bioavailability, achieved through a specific method involving the dissolution of itraconazole and a hydrophilic polymer, followed by spray-drying to create solid dispersions suitable for various oral dosage forms.

Career Highlights

Kye-Hyun Kim is currently associated with Choongwae Pharma Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that enhance patient outcomes.

Collaborations

Some of his notable coworkers include Sang-Heon Lee and Jae-Young Jung, who contribute to the collaborative efforts in research and development at Choongwae Pharma Corporation.

Conclusion

Kye-Hyun Kim's contributions to pharmaceutical innovations demonstrate his commitment to improving drug efficacy and safety. His patents reflect a deep understanding of drug formulation, which has the potential to significantly impact patient care.